NUTEX HEALTH INC.: 10-Q filed 2023-08-09
What NUTEX HEALTH INC. reported in its quarterly report filed 2023-08-09 (fiscal Q2 2023): 48 published measures, 135 facts as tagged in accession 0001558370-23-014212.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2023-08-09
- Fiscal period
- fiscal Q2 2023
- Accession
- 0001558370-23-014212 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NUTEX HEALTH INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 436,234,448 | USD | |
| At 2022-12-31 | 431,751,985 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 328,008,269 | USD | |
| At 2022-12-31 | 311,424,585 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 92,618,459 | USD | |
| At 2022-12-31 | 95,862,701 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 32,754,330 | USD | |
| At 2022-12-31 | 34,255,264 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | -3,479,047 | USD | 91 |
| 2023-01-01 to 2023-06-30 | -8,626,326 | USD | 181 |
| 2022-04-01 to 2022-06-30 | -19,284,846 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 2,245,456 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-01-01 to 2023-06-30 | 1,064,332 | USD | 181 |
| 2022-01-01 to 2022-06-30 | 53,403,059 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | 3,069,919 | USD | 91 |
| 2023-01-01 to 2023-06-30 | 7,446,902 | USD | 181 |
| 2022-04-01 to 2022-06-30 | 8,029,903 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 16,621,726 | USD | 181 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | 58,924,454 | USD | 91 |
| 2023-01-01 to 2023-06-30 | 115,253,871 | USD | 181 |
| 2022-04-01 to 2022-06-30 | 58,047,933 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 137,175,175 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-01-01 to 2023-06-30 | 5,920,793 | USD | 181 |
| 2022-01-01 to 2022-06-30 | -35,594,012 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-01-01 to 2023-06-30 | -8,486,059 | USD | 181 |
| 2022-01-01 to 2022-06-30 | -6,326,710 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | -371,912,251 | USD | |
| At 2022-12-31 | -363,285,925 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | 656,563,166 | shares | 91 |
| 2023-01-01 to 2023-06-30 | 653,755,031 | shares | 181 |
| 2022-04-01 to 2022-06-30 | 646,370,173 | shares | 91 |
| 2022-01-01 to 2022-06-30 | 619,728,949 | shares | 181 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | 656,563,166 | shares | 91 |
| 2023-01-01 to 2023-06-30 | 653,755,031 | shares | 181 |
| 2022-04-01 to 2022-06-30 | 646,370,173 | shares | 91 |
| 2022-01-01 to 2022-06-30 | 626,992,817 | shares | 181 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | -0.01 | USD/shares | 91 |
| 2023-01-01 to 2023-06-30 | -0.01 | USD/shares | 181 |
| 2022-04-01 to 2022-06-30 | -0.03 | USD/shares | 91 |
| 2022-01-01 to 2022-06-30 | 0 | USD/shares | 181 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | -0.01 | USD/shares | 91 |
| 2023-01-01 to 2023-06-30 | -0.01 | USD/shares | 181 |
| 2022-04-01 to 2022-06-30 | -0.03 | USD/shares | 91 |
| 2022-01-01 to 2022-06-30 | 0 | USD/shares | 181 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | -815,612 | USD | 91 |
| 2023-01-01 to 2023-06-30 | -1,726,271 | USD | 181 |
| 2022-04-01 to 2022-06-30 | 19,653,286 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 19,829,609 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 83,062,145 | USD | |
| At 2022-12-31 | 82,094,352 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | -362,538 | USD | 91 |
| 2023-01-01 to 2023-06-30 | -4,807,625 | USD | 181 |
| 2022-04-01 to 2022-06-30 | -1,378,477 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 27,860,496 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 92,075,194 | USD | |
| At 2022-12-31 | 97,973,924 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | 4,843,048 | USD | 91 |
| 2023-01-01 to 2023-06-30 | 7,983,137 | USD | 181 |
| 2022-04-01 to 2022-06-30 | 4,369,609 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 6,225,583 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 57,443,291 | USD | |
| At 2022-12-31 | 54,862,969 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 16,424,368 | USD | |
| At 2022-12-31 | 23,614,387 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 17,010,637 | USD | |
| At 2022-12-31 | 17,010,637 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 50,676,301 | USD | |
| At 2022-12-31 | 57,777,386 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | 10,009,461 | USD | 91 |
| 2023-01-01 to 2023-06-30 | 19,302,271 | USD | 181 |
| 2022-04-01 to 2022-06-30 | 8,016,398 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 14,592,921 | USD | 181 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 2,450,776 | USD | |
| At 2022-12-31 | 3,533,285 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | 9,646,923 | USD | 91 |
| 2023-01-01 to 2023-06-30 | 14,494,646 | USD | 181 |
| 2022-04-01 to 2022-06-30 | 6,637,921 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 42,453,417 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 660,742,624 | shares | |
| At 2022-12-31 | 650,223,840 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 463,869,968 | USD | |
| At 2022-12-31 | 458,498,402 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 108,226,179 | USD | |
| At 2023-03-31 | 109,538,154 | USD | |
| At 2022-12-31 | 120,327,400 | USD | |
| At 2022-06-30 | 556,082,706 | USD | |
| At 2022-03-31 | 187,423,361 | USD | |
| At 2021-12-31 | 191,581,010 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 17,111,817 | USD | |
| At 2022-12-31 | 20,466,632 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 97,871,064 | USD | |
| At 2022-12-31 | 95,106,230 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 14,808,919 | USD | |
| At 2022-12-31 | 13,011,878 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 20,418,551 | USD | |
| At 2022-12-31 | 21,191,390 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 4,858,546 | USD | |
| At 2022-12-31 | 1,869,806 | USD |
Net deferred tax assets
Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 2,400,000 | USD |
Net deferred tax liabilities
Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2023-06-30 | 8,728,100 | USD | |
| At 2022-12-31 | 10,452,211 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | -5,082,058 | USD | 91 |
| 2023-01-01 to 2023-06-30 | -12,914,689 | USD | 181 |
| 2022-04-01 to 2022-06-30 | -4,344,864 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 20,657,590 | USD | 181 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | -4,266,446 | USD | 91 |
| 2023-01-01 to 2023-06-30 | -11,188,418 | USD | 181 |
| 2023-01-01 to 2023-03-31 | -6,921,972 | USD | 90 |
| 2022-04-01 to 2022-06-30 | -23,998,150 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 827,981 | USD | 181 |
| 2022-01-01 to 2022-03-31 | 24,826,131 | USD | 90 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | 9,759,816 | USD | 91 |
| 2023-01-01 to 2023-06-30 | 16,935,360 | USD | 181 |
| 2022-04-01 to 2022-06-30 | 4,076,566 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 10,653,089 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-01-01 to 2023-06-30 | 8,162,907 | USD | 181 |
| 2022-01-01 to 2022-06-30 | 5,529,346 | USD | 181 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | 400,000 | USD | 91 |
| 2023-01-01 to 2023-06-30 | 800,000 | USD | 181 |
| 2022-04-01 to 2022-06-30 | 400,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 400,000 | USD | 181 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-04-01 to 2023-06-30 | 123,528 | USD | 91 |
| 2023-01-01 to 2023-06-30 | -123,927 | USD | 181 |
| 2022-04-01 to 2022-06-30 | 1,403,222 | USD | 91 |
| 2022-01-01 to 2022-06-30 | -977,323 | USD | 181 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-01-01 to 2023-06-30 | -1,724,111 | USD | 181 |
| 2022-01-01 to 2022-06-30 | 12,013,748 | USD | 181 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-01-01 to 2023-06-30 | 858,773 | USD | 181 |
| 2022-01-01 to 2022-06-30 | 5,705,603 | USD | 181 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-01-01 to 2023-06-30 | 737,000 | USD | 181 |
| 2022-01-01 to 2022-06-30 | 631,400 | USD | 181 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-01-01 to 2023-06-30 | -6,921,239 | USD | 181 |
| 2022-01-01 to 2022-06-30 | -19,745,666 | USD | 181 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2023-01-01 to 2023-06-30 | -1,082,509 | USD | 181 |
| 2022-01-01 to 2022-06-30 | 93,004 | USD | 181 |
Inspect the source
- Entity
- NUTEX HEALTH INC. / CIK 0001479681
- Captured
- 2026-09-20T09:08:51.281Z
- SEC response SHA-256
1e4c4278b3e624c66aafe376ea707c33deb0bbd1075a4c39e2ccf48ef8d47252
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001479681.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))